Coumarin

CAS No. 91-64-5

Coumarin( Coumarin | NSC 8774 | NSC-8774 | NSC8774 )

Catalog No. M16582 CAS No. 91-64-5

Extracted from Tonka bean,incense Liatris.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 30 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Coumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    Extracted from Tonka bean,incense Liatris.
  • Description
    Extracted from Tonka bean,incense Liatris; Suitability:Alcohol,ether,chloroform,pyridine,volatile oil and alkali hydroxide solution;Store the product in sealed,cool and dry condition.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Coumarin | NSC 8774 | NSC-8774 | NSC8774
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Factor Xa
  • Recptor
    Factor Xa| VK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    91-64-5
  • Formula Weight
    146.14
  • Molecular Formula
    C9H6O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 29 mg/mL (198.43 mM); DMSO: 29 mg/mL (198.43 mM)
  • SMILES
    O=C1C=CC2=CC=CC=C2O1
  • Chemical Name
    2H-1-Benzopyran-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Egan D, et al. Drug Metab Rev, 1990, 22(5), 503-529.
molnova catalog
related products
  • Eribaxaban

    A potent, selective and orally efficacious factor Xa (FXa) inhibitor with IC50 of 0.32 nM.

  • Zifaxaban

    Zifaxaban (TY-602) is an orally active, competitive and selective inhibitor of factor Xa (FXa) with an IC50 of 11.1 nM for human FXa.Zifaxaban has a very high affinity, more than 10,000-fold higher than that of other serine proteases.Zifaxaban can be used to study arterial and venous thrombosis.

  • Edoxaban

    Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.